IL6 and candidiasis: We theorize that as emapalumab blocks IFNγ, subsequently blocking neutrophil activation and IL-6 modulation; it led to our patient being more susceptible to systemic candidiasis, resulting in fungal emboli that led to her intraparenchymal hemorrhage [8]).